NeoPharm Investigators to Present New and Updated Clinical Data on Cintredekin Besudotox at the American Association of Neurological Surgeons Annual Meeting.
Business Wire › April 17, 2006
Linked as:
Extract
NeoPharm Investigators to Present New and Updated Clinical Data on Cintredekin Besudotox at the American Association of Neurological Surgeons Annual Meeting.
NeoPharm, Inc. (NASDAQ/NM:NEOL):
Who/What: NeoPharm, Inc. (NASDAQ/NM:NEOL) clinical data presentations on cintredekin besudotox ("IL13-PE38QQR") Where: American Association of Neurological Surgeons (AANS) 2006 Annual Meeting April 22-27...See the full content of this document
Sponsored links
